{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:49:49Z","timestamp":1790131789174,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5P30CA021765-42"],"award-info":[{"award-number":["5P30CA021765-42"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA021765"],"award-info":[{"award-number":["P30CA021765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015394","name":"American Society for Transplantation and Cellular Therapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00467-024-06331-7","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T06:47:56Z","timestamp":1710917276000},"page":"2495-2503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3178-1247","authenticated-orcid":false,"given":"Yonique","family":"Petgrave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Selukar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Epperly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel DeLos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Triplett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee C.","family":"Talleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"6331_CR1","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude SL, Frey N, Shaw PA, Aplenc R, Barrett DM, Bunin NJ et al (2014) Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 371:1507\u20131517","journal-title":"N Engl J Med"},{"key":"6331_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMoa1709866","volume":"378","author":"SL Maude","year":"2018","unstructured":"Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H et al (2018) Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med 378:439\u2013448","journal-title":"N Engl J Med"},{"key":"6331_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","volume":"33","author":"PJ Hayden","year":"2022","unstructured":"Hayden PJ, Roddie C, Bader P, Basak GW, Bonig H, Bonini C et al (2022) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Ann Oncol 33:259\u2013275","journal-title":"Ann Oncol"},{"key":"6331_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.hoc.2022.03.005","volume":"36","author":"AC Talleur","year":"2022","unstructured":"Talleur AC, Myers R, Annesley C, Shalabi H (2022) Chimeric antigen receptor T-cell therapy: current status and clinical outcomes in pediatric hematologic malignancies. Hematol Oncol Clin North Am 36:701\u2013727","journal-title":"Hematol Oncol Clin North Am"},{"key":"6331_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1182\/bloodadvances.2022007246","volume":"7","author":"H Stefanski","year":"2023","unstructured":"Stefanski H, Eaton A, Baggott C, Rossoff J, Verneris MR, Keating AK et al (2023) Higher doses of tisagenlecleucel associate with improved outcomes: a report from the pediatric real-world CAR consortium. Blood Adv 7:541\u2013548","journal-title":"Blood Adv"},{"key":"6331_CR6","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1097\/CCM.0000000000002053","volume":"45","author":"JC Fitzgerald","year":"2017","unstructured":"Fitzgerald JC, Weiss SL, Maude SL, Barrett DM, Lacey SF, Melenhorst JJ et al (2017) Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia. Crit Care Med 45:e124\u2013e131","journal-title":"Crit Care Med"},{"key":"6331_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN et al (2019) ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25:625\u2013638","journal-title":"Biol Blood Marrow Transplant"},{"key":"6331_CR8","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","volume":"377","author":"SJ Schuster","year":"2017","unstructured":"Schuster SJ, Svoboda J, Chong EA, Nasta SD, Mato AR, Anak \u00d6 et al (2017) Chimeric antigen receptor T cells in refractory B-cell lymphomas. N Engl J Med 377:2545\u20132554","journal-title":"N Engl J Med"},{"key":"6331_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1053\/j.ajkd.2019.10.011","volume":"76","author":"S Gupta","year":"2020","unstructured":"Gupta S, Seethapathy H, Strohbehn IA, Frigault MJ, O\u2019Donnell EK, Jacobson CA et al (2020) Acute kidney injury and electrolyte abnormalities after chimeric antigen receptor T-cell (CAR-T) therapy for diffuse large B-cell lymphoma. Am J Kidney Dis 76:63\u201371","journal-title":"Am J Kidney Dis"},{"key":"6331_CR10","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.bbmt.2016.03.014","volume":"22","author":"SJ Kizilbash","year":"2016","unstructured":"Kizilbash SJ, Kashtan CE, Chavers BM, Cao Q, Smith AR (2016) Acute kidney injury and the risk of mortality in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 22:1264\u20131270","journal-title":"Biol Blood Marrow Transplant"},{"key":"6331_CR11","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1053\/j.ajkd.2020.08.017","volume":"77","author":"MD Lee","year":"2021","unstructured":"Lee MD, Strohbehn IA, Seethapathy HS, Rusibamayila N, Casey KS, Gupta S et al (2021) Acute kidney injury after the CAR-T therapy tisagenlecleucel. Am J Kidney Dis 77:990\u2013992","journal-title":"Am J Kidney Dis"},{"key":"6331_CR12","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.mayocp.2022.05.018","volume":"97","author":"N Farooqui","year":"2022","unstructured":"Farooqui N, Sy-Go JPT, Miao J, Mehta R, Vaughan LE, Bennani NN et al (2022) Incidence and risk factors for acute kidney injury after chimeric antigen receptor T-cell therapy. Mayo Clin Proc 97:1294\u20131304","journal-title":"Mayo Clin Proc"},{"key":"6331_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2215\/CJN.12871117","volume":"13","author":"KD Jhaveri","year":"2018","unstructured":"Jhaveri KD, Rosner MH (2018) Chimeric antigen receptor T cell therapy and the kidney: what the nephrologist needs to know. Clin J Am Soc Nephrol 13:796\u2013798","journal-title":"Clin J Am Soc Nephrol"},{"key":"6331_CR14","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.ekir.2021.02.013","volume":"6","author":"SR Kanduri","year":"2021","unstructured":"Kanduri SR, Cheungpasitporn W, Thongprayoon C, Petnak T, Lin Y, Kovvuru K et al (2021) Systematic review of risk factors and incidence of acute kidney injury among patients treated with CAR-T cell therapies. Kidney Int Rep 6:1416\u20131422","journal-title":"Kidney Int Rep"},{"issue":"232","key":"6331_CR15","doi-asserted-by":"publisher","first-page":"S168","DOI":"10.1016\/j.bbmt.2018.12.307","volume":"25","author":"RM Myers","year":"2019","unstructured":"Myers RM, Fitzgerald J, Elgarten CW, Getz KD, Li Y, Hogan J, Dinofia A, Burrows EK, Aplenc R, Grupp SA, Laskin B, Maude SL (2019) Acute kidney injury after chimeric antigen receptor T-cell therapy for pediatric acute lymphoblastic leukemia. Biol Blood Marrow Transplant 25:S168\u2013S169","journal-title":"Biol Blood Marrow Transplant"},{"key":"6331_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.bbmt.2020.02.012","volume":"26","author":"V Gutgarts","year":"2020","unstructured":"Gutgarts V, Jain T, Zheng J, Maloy MA, Ruiz JD, Pennisi M et al (2020) Acute kidney injury after CAR-T cell therapy: low incidence and rapid recovery. Biol Blood Marrow Transplant 26:1071\u20131076","journal-title":"Biol Blood Marrow Transplant"},{"key":"6331_CR17","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.bbmt.2012.06.006","volume":"18","author":"BL Laskin","year":"2012","unstructured":"Laskin BL, Nehus E, Goebel J, Khoury JC, Davies SM, Jodele S (2012) Cystatin C-estimated glomerular filtration rate in pediatric autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 18:1745\u20131752","journal-title":"Biol Blood Marrow Transplant"},{"key":"6331_CR18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/bmt.2016.343","volume":"52","author":"IG Glezerman","year":"2017","unstructured":"Glezerman IG, Devlin S, Maloy M, Bui M, Jaimes EA, Giralt SA et al (2017) Long term renal survival in patients undergoing T-cell depleted versus conventional hematopoietic stem cell transplants. Bone Marrow Transplant 52:733\u2013738","journal-title":"Bone Marrow Transplant"},{"key":"6331_CR19","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s00467-017-3852-8","volume":"33","author":"G Filler","year":"2018","unstructured":"Filler G, Lee M (2018) Educational review: measurement of GFR in special populations. Pediatr Nephrol 33:2037\u20132046","journal-title":"Pediatr Nephrol"},{"key":"6331_CR20","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.1182\/bloodadvances.2021006293","volume":"6","author":"AC Talleur","year":"2022","unstructured":"Talleur AC, Qudeimat A, M\u00e9tais JY, Langfitt D, Mamcarz E, Crawford JC et al (2022) Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL. Blood Adv 6:5737\u20135749","journal-title":"Blood Adv"},{"key":"6331_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ekir.2020.11.028","volume":"6","author":"SW Benoit","year":"2021","unstructured":"Benoit SW, Kathman T, Patel J, Stegman M, Cobb C, Hoehn J et al (2021) GFR estimation after cystatin C reference material change. Kidney Int Rep 6:429\u2013436","journal-title":"Kidney Int Rep"},{"key":"6331_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ki.2012.169","volume":"82","author":"GJ Schwartz","year":"2012","unstructured":"Schwartz GJ, Schneider MF, Maier PS, Moxey-Mims M, Dharnidharka VR, Warady BA et al (2012) Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82:445\u2013453","journal-title":"Kidney Int"},{"key":"6331_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.kint.2021.06.028","volume":"100","author":"NH Lameire","year":"2021","unstructured":"Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC et al (2021) Harmonizing acute and chronic kidney disease definition and classification: report of a kidney disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 100:516\u2013526","journal-title":"Kidney Int"},{"key":"6331_CR24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/s41409-018-0428-6","volume":"54","author":"SW Benoit","year":"2019","unstructured":"Benoit SW, Dixon BP, Goldstein SL, Bennett MR, Lane A, Lounder DT et al (2019) A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant 54:1453\u20131461","journal-title":"Bone Marrow Transplant"},{"key":"6331_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","volume":"15","author":"SS Neelapu","year":"2018","unstructured":"Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL et al (2018) Chimeric antigen receptor T-cell therapy - assessment and management of toxicities. Nat Rev Clin Oncol 15:47\u201362","journal-title":"Nat Rev Clin Oncol"},{"key":"6331_CR26","doi-asserted-by":"crossref","unstructured":"Davila ML, Riviere I, Wang X, Bartido S, Park J, Curran K et al (2014) Efficacy and toxicity management of 19\u201328z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med 6:224ra25","DOI":"10.1126\/scitranslmed.3008226"},{"key":"6331_CR27","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1182\/blood-2013-08-519413","volume":"122","author":"JN Kochenderfer","year":"2013","unstructured":"Kochenderfer JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG et al (2013) Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood 122:4129\u20134139","journal-title":"Blood"},{"key":"6331_CR28","doi-asserted-by":"publisher","first-page":"795158","DOI":"10.3389\/fped.2022.795158","volume":"10","author":"A Pechlaner","year":"2022","unstructured":"Pechlaner A, Kropshofer G, Crazzolara R, Hetzer B, Pechlaner R, Cortina G (2022) Mortality of hemato-oncologic patients admitted to a pediatric intensive care unit: a single-center experience. Front Pediatr 10:795158","journal-title":"Front Pediatr"},{"key":"6331_CR29","first-page":"159","volume":"3","author":"JC Fitzgerald","year":"2014","unstructured":"Fitzgerald JC, Williams D, Laskin BL (2014) Acute kidney injury in pediatric hematopoietic stem cell transplant recipients. J Pediatr Intensive Care 3:159\u2013168","journal-title":"J Pediatr Intensive Care"},{"key":"6331_CR30","doi-asserted-by":"publisher","unstructured":"Raina R, Herrera N, Krishnappa V, Sethi SK, Deep A, Kao WM et al (2017) Hematopoietic stem cell transplantation and acute kidney injury in children: A comprehensive review. Pediatr Transplant 21:e12935. https:\/\/doi.org\/10.1111\/petr.12935","DOI":"10.1111\/petr.12935"},{"key":"6331_CR31","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00467-022-05448-x","volume":"37","author":"R Raina","year":"2022","unstructured":"Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT et al (2022) Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol 37:1179\u20131203","journal-title":"Pediatr Nephrol"},{"key":"6331_CR32","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMra1404711","volume":"374","author":"S Hingorani","year":"2016","unstructured":"Hingorani S (2016) Renal complications of hematopoietic-cell transplantation. N Engl J Med 374:2256\u20132267","journal-title":"N Engl J Med"},{"key":"6331_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/j.ackd.2010.05.002","volume":"17","author":"JR Weinstein","year":"2010","unstructured":"Weinstein JR, Anderson S (2010) The aging kidney: physiological changes. Adv Chronic Kidney Dis 17:302\u2013307","journal-title":"Adv Chronic Kidney Dis"},{"issue":"Pt B","key":"6331_CR34","doi-asserted-by":"publisher","first-page":"107072","DOI":"10.1016\/j.intimp.2020.107072","volume":"89","author":"H Zhou","year":"2020","unstructured":"Zhou H, Yang M, Cui L, Jiang J (2020) Chimeric antigen receptor T cell therapy and nephrotoxicity: from diagnosis to treatment strategies. Int Immunopharmacol 89(Pt B):107072","journal-title":"Int Immunopharmacol"},{"key":"6331_CR35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1182\/bloodadvances.2019000952","volume":"4","author":"M Pennisi","year":"2020","unstructured":"Pennisi M, Jain T, Santomasso BD, Mead E, Wudhikarn K, Silverberg ML et al (2020) Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management. Blood Adv 4:676\u2013686","journal-title":"Blood Adv"},{"key":"6331_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jamapediatrics.2015.54","volume":"169","author":"M Zappitelli","year":"2015","unstructured":"Zappitelli M, Greenberg JH, Coca SG, Krawczeski CD, Li S, Thiessen-Philbrook HR et al (2015) Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery. JAMA Pediatr 169:583\u2013591","journal-title":"JAMA Pediatr"},{"key":"6331_CR37","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2215\/CJN.00690110","volume":"5","author":"K Soto","year":"2010","unstructured":"Soto K, Coelho S, Rodrigues B, Martins H, Frade F, Lopes S et al (2010) Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol 5:1745\u20131754","journal-title":"Clin J Am Soc Nephrol"},{"key":"6331_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00467-012-2341-3","volume":"28","author":"EJ Nehus","year":"2013","unstructured":"Nehus EJ, Laskin BL, Kathman TI, Bissler JJ (2013) Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury. Pediatr Nephrol 28:453\u2013461","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06331-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06331-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06331-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T07:07:38Z","timestamp":1719299258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06331-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["6331"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06331-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3396661\/v1","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"28 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SG consults\/consulted for TESSA Therapeutics, TIDAL, Catamaran, and Novartis and is DSMB member of Immatics. SG and RE have patents\/patent applications in the fields of T-cell and\/or gene therapy for cancer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}